Suchergebnisse - "Venkatakrishnan, Karthik"

PubPharm (354)

101

Single-Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK-788) in Healthy Volunteers : Low-Fat Meal Effect and Relative Bioavailability of 2 Capsule Products

enthalten in: Clinical pharmacology in drug development | 2021

von Zhang, S. | Jin, S. | Griffin, C. | +6

102

A METHOD FOR ENHANCING THE PHARMACOKINETICS OR INCREASING THE PLASMA CONCENTRATION OF METHYL 3-((METHYLSULFONYL)AMINO)-2-(((4-PHENYLCYCLOHEXYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE OR A SALT THEREOF WITH AN INHIBITOR OF CYTOCHROME P450

enthalten in: Europäisches Patentamt | 2021

von ROGGE MARK | FAESSEL HELENE | LU HONG | +3

103

A METHOD FOR ENHANCING THE PHARMACOKINETICS OR INCREASING THE PLASMA CONCENTRATION OF METHYL 3-((METHYLSULFONYL)AMINO)-2-(((4-PHENYLCYCLOHEXYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE OR A SALT THEREOF WITH AN INHIBITOR OF CYTOCHROME P450

enthalten in: Europäisches Patentamt | 2021

von ROGGE MARK | FAESSEL HELENE | LU HONG | +3

104

METHODS FOR CANCER THERAPY

enthalten in: Europäisches Patentamt | 2021

von HUI AI-MIN | LABOTKA RICHARD | GUPTA NEERAJ | +2

105

Asia-inclusive global development of pevonedistat : Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial

enthalten in: Clinical and translational science | 2021

von Zhou, X. | Friedlander, S. | Kupperman, E. | +11

106

Application of Machine Learning in Translational Medicine : Current Status and Future Opportunities

enthalten in: The AAPS journal | 2021

von Terranova, N. | Venkatakrishnan, K. | Benincosa, L.

107

Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities

enthalten in: The AAPS journal | 2021

von Terranova, N. | Venkatakrishnan, K. | Benincosa, L.

108

Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities

enthalten in: AAPS PharmSci | 2021

von Terranova, N. | Venkatakrishnan, K. | Benincosa, L.

109

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2021

von Zhou, X. | Sedarati, F. | Faller, D. | +7

110

Effect of severe renal impairment on the pharmacokinetics of brigatinib

enthalten in: Investigational new drugs | 2021

von Gupta, N. | Hanley, M. | Kerstein, D. | +4